Key result
Elevated fasting glucose is linked to ~2.9-fold higher prevalence of hypertriglyceridemia.
Why the study?
Metabolic diseases are common in Indonesia, and the relationship between fasting blood glucose levels and lipid profiles has not been analyzed in a private clinical laboratory setting.
Cross-Sectional (n=322)
No
Relative Risk: 2.93 (95% CI 1.99–4.31)
Absolute Event Rate: 65% vs 22.2%
p-value: p=0.0001
Elevated fasting blood glucose ≥126 mg/dL is significantly associated with higher triglycerides and lower HDL, emphasizing the physiological interplay between glucose and lipid metabolism.
Elevated glucose may flag atherogenic dyslipidemia; cross-sectional data leaves open causality and needs prospective confirmation.
Metabolic diseases have become a common health problem faced by many people in Indonesia. Two important indicators for monitoring the onset of metabolic diseases are blood glucose and blood lipids. Blood glucose has a strong physiological relationship with lipid metabolism, including triglycerides, total cholesterol, LDL, and HDL. Excess blood glucose that is not utilized by the cells is converted into fatty acids through the process of lipogenesis in the liver, which are then stored as triglycerides, leading to elevated blood lipid levels that may contribute to the development of metabolic diseases. One private clinical laboratory in Tangerang City has received numerous test requests related to blood glucose and blood lipids. However, no analysis has been conducted to date, highlighting the need for a research study. This study employed a cross-sectional design and analyzed a total of 322 samples that met the inclusion criteria. The results showed a significant association between fasting blood glucose levels and triglyceride levels (p-value = 0.0001, PRR = 2.93), as well as HDL levels (p-value = 0.01, PRR = 1.469). However, no significant relationship was found between fasting blood glucose and total cholesterol (p-value = 0.209, PRR = 1.710) or LDL levels (p-value = 0.977, PRR = 0.993). These findings emphasize the importance of controlling blood glucose levels to prevent lipid metabolism disorders, even though not all lipid profile components showed a similar association.
No takes yet. Share an insight, caveat, or question.
Novendy et al. (2026) conducted a cross-sectional in Healthy or general clinic attendees (metabolic risk) (n=322). Elevated fasting blood glucose (≥ 126 mg/dL) vs. Fasting blood glucose < 126 mg/dL was evaluated on Elevated triglycerides (≥ 150 mg/dL) (PRR 2.93, 95% CI 1.99-4.31, p=0.0001). Elevated fasting blood glucose levels were significantly associated with an increased prevalence of high triglycerides (PRR 2.93) and low HDL cholesterol (PRR 1.47).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: